Paul, Weiss, Rifkind, Wharton & Garrison LLP announced today the addition of Christopher M. Wilson as a partner in its Litigation Department, based in Washington. Wilson, a former trial lawyer at the U.S. Department of Justice’s Antitrust Division, brings experience in antitrust matters including merger control, cross-border antitrust investigations and private litigation involving complex antitrust and consumer protection issues.
Brad S. Karp, Chairman of Paul, Weiss, expressed his enthusiasm for Wilson’s arrival, stating, “I’m delighted to welcome Chris, a dynamic and talented antitrust advisor, to the partnership. Chris will further deepen our leading global antitrust and merger clearance capabilities, at a time when our clients are navigating an increasingly complex antitrust landscape.”
Andrew C. Finch, global co-chair of the Antitrust Practice, highlighted Wilson’s accomplishments at the DOJ, noting, “Chris’s time at the Antitrust Division has been distinguished by a remarkable track record of achievements. He will be a fantastic addition to the firm and his expertise will further solidify our presence in Washington.”
Wilson has managed major merger reviews for clients such as Pioneer Natural Resources in its acquisition by ExxonMobil, Platinum Equity in its acquisition of Solenis, and GE Healthcare in its acquisition of BK Medical. He has also handled cross-border investigations involving multiple jurisdictions, including the European Union, the United Kingdom and Canada, covering industries such as health insurance, transportation, technology and biotechnology.
Read more: EX-Assistant Chief of DOJ’s Antitrust Division Joins Paul, Weiss
Scott A. Sher, global co-chair of the Antitrust Practice, emphasized Wilson’s practical experience, saying, “Chris is a commercial, thoughtful advisor who has managed numerous major merger reviews, both within the DOJ and in private practice. His addition will benefit our clients across a range of industries, and we are thrilled that he is joining us.”
Before entering private practice, Wilson served as a trial attorney in the DOJ’s Antitrust Division, where he was involved in high-profile cases like CVS/Aetna and Bayer/Monsanto, earning the Division’s Award of Distinction twice. He is an active member of the ABA Antitrust Section’s Transportation & Energy Industries Committee and a published author in various antitrust publications.
Wilson expressed his excitement about joining Paul, Weiss, stating, “I am thrilled to be joining Paul, Weiss, a firm known for its inclusive and collaborative culture, and look forward to working with the firm’s top-notch clients and incredibly talented lawyers.”
Wilson holds a B.A. from New York University and a J.D. from Columbia University, where he was a Harlan Fiske Stone scholar and served as an editor on the Columbia Business Law Review.
Source: Paul Weiss
Featured News
Clifford Chance Expands Global Antitrust Team with New Partner
Dec 6, 2024 by
CPI
Spain’s Financial Regulator Awaits Antitrust Decision on BBVA’s Hostile Bid for Sabadell
Dec 5, 2024 by
CPI
RealPage Seeks Dismissal of DOJ Antitrust Suit, Citing Legal Flaws
Dec 5, 2024 by
CPI
EU Competition Chief Signals Potential Google Breakup Amid Big Tech Scrutiny
Dec 5, 2024 by
CPI
Turkey Closes Antitrust Probe into Meta’s Threads-Instagram Practices
Dec 5, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Moats & Entrenchment
Nov 29, 2024 by
CPI
Assessing the Potential for Antitrust Moats and Trenches in the Generative AI Industry
Nov 29, 2024 by
Allison Holt, Sushrut Jain & Ashley Zhou
How SEP Hold-up Can Lead to Entrenchment
Nov 29, 2024 by
Jay Jurata, Elena Kamenir & Christie Boyden
The Role of Moats in Unlocking Economic Growth
Nov 29, 2024 by
CPI
Overcoming Moats and Entrenchment: Disruptive Innovation in Generative AI May Be More Successful than Regulation
Nov 29, 2024 by
Simon Chisholm & Charlie Whitehead